About
Dr Wenying Lu (a.k.a. Monica) is a Postdoctoral Researcher and Laboratory Manager with the Respiratory Translational Research Group at the University of Tasmania, Launceston. Her current research interests involve microbial pathogenesis in IPF and LAM, including implications for COVID-19. Dr Lu is also actively investigating the role of epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT) in patients with IPF and LAM. She is very enthusiastic to enhance her understanding on ILDs.
Dr Lu was awarded with her PhD degree in 2017 from the School of Pharmacy, University of Tasmania, examining the biological and behavioural markers of smoking reduction. Dr Lu is also manager of the Tasmanian Respiratory Tissue Bank, and Coordinator of the Tasmanian Lung Cancer Registry. Her other research interests involve understanding the pathogenesis of COPD, lung cancer, and asthma and COPD overlap (ACO). She is also investigating the effects of electronic cigarettes/vaping on human lung cellular changes.